ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000824.1|Scytonemin_1 # 1 # 945 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.415	BGC0000824.1|Scytonemin_1 	1	945	-	Loose	1000	25.7942	lsaA	31.43	3000300	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	ATGGTTTTAAGTCAATATCAACGTGCTGTAGGCGTATTTACTCATCGTCGAGATGCAGAACAGGCCCTACATGAGTTGAGAGATTCTGGCTTGGCGATGGACAAAGTATCTGTAGTTGTACAGAATATAGCTCGCAATCATGAGATTGCTAATGATGAAATTAAAGAGCGCACTGGTGATAAAGCCGACGAGGGTGCAACAGTAGGAGGGCTTTCAGGCGGCGCTGTTGGTGGGTTGACTGGTTTATTAGTAGGTCTTGGGACTTTAGCAATCCCTGGAGTTGGGCCAATAATGCTGGCTGGCGCAGCTGCAACTGCTTTGGTTACAACCCTTGTTGGTGCAAGTATTGGTGCTGCTACTGGCACTTTTGCTGGTGCATTAGTTGGTTGGGGAATATCGGAAGAGCAAGCTAGAGCATATAACGAGCGAGTAGAGCATGGGCACTATTTCATAATCGTGGATTGTACATCTTTTGAAATTGCTAAAGTAGAAGCAATTCTACAGCGTTGGGGTATTGAAGAATTTGGTATTTACGAGCCTCTAAGTAGTGAGCAATTATCTACAAACTCTGCTACTACCATTCCTAATAAAAGTGGGATTTTAAGTAAGTATGCTGTTAGTTGTTTTGATAGCATAGATAATGCTAAAGCTGCAATTAACGATATGTATATAGCAGGTTTTTCAGGAAACCAGATGTCTTTAATTTGTAAAGATTCTTCTCAATTTATTGGGCTAACTGGTATTAATTTAAGTGAGCGCTTTGACGCTATGAGGCTAGGAATAGCAGATGAATGGGCACGTTTTTACAACGAGCAAATTTCTCAAGGCAATTACATACTCATCGTTAGTGGCACAGACAAAGAGCTTGAGCAGGCTAGCTTGATTTTGGGCAATTATGGAGTTCAGGAATGTCAAATTTATGACCCGATGTTAATCCGTTCTTGA	MVLSQYQRAVGVFTHRRDAEQALHELRDSGLAMDKVSVVVQNIARNHEIANDEIKERTGDKADEGATVGGLSGGAVGGLTGLLVGLGTLAIPGVGPIMLAGAAATALVTTLVGASIGAATGTFAGALVGWGISEEQARAYNERVEHGHYFIIVDCTSFEIAKVEAILQRWGIEEFGIYEPLSSEQLSTNSATTIPNKSGILSKYAVSCFDSIDNAKAAINDMYIAGFSGNQMSLICKDSSQFIGLTGINLSERFDAMRLGIADEWARFYNEQISQGNYILIVSGTDKELEQASLILGNYGVQECQIYDPMLIRS	MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS	63.05	gnl|BL_ORD_ID|1191|hsp_num:0	1298			243	348	clindamycin; quinupristin; dalfopristin; pleuromutilin
BGC0000824.1|Scytonemin_3 # 2363 # 2482 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.458	BGC0000824.1|Scytonemin_3 	2363	2482	-	Loose	300	20.7866	dfrA3	32.35	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGCCAATGCATCGACCTGCAATGCTAATGCATCGACTTGCAATGCCAATACATCGACCTACAATGCCAATGCATCAACCTGCAATGCCAATACATCGACCTGCAATGCTAATGCATTGA	MPMHRPAMLMHRLAMPIHRPTMPMHQPAMPIHRPAMLMH	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	24.07	gnl|BL_ORD_ID|470|hsp_num:0	511			60	162	trimethoprim
BGC0000824.1|Scytonemin_5 # 3780 # 5009 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.455	BGC0000824.1|Scytonemin_5 	3780	5009	-	Loose	500	27.7202	OXA-601	24.39	3005822	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGTAAGCATACAAGACATCAAGACTGCAACTATCCAACCAGATTCTTTAGGCAGATTTGGAAGATTTGGTGGTAAATACGTCCCCGAAACTTTAATGCCTGCATTAAGTGAGTTAGAAGCAGCATTTCAAAAATATCGCAACGAGCCGAGTTTCCAAGCAGAACTGCAAAACCTACTGCGCGATTACGTCGGACGACCCAGCCCATTATATTTTGCTGAACGCTTGACAGCAAACTACGCTAGACCAGATGGCACTGGGCCGCAAATCTATTTAAAGCGTGAGGATTTAAATCATACAGGCGCTCACAAAATTAATAATGCTTTAGCTCAGGTGTTACTCGCTAAACGTATGGGTAAGCAAAGGGTTATTGCCGAGACAGGTGCAGGACAACATGGCGTAGCAACTGCAACTGTCTGTGCGCGGTTTGGTTTGAGATGTGTGATTTACATGGGCATCCACGATATGGAACGCCAAGCCCTGAATGTCTTCCGCATGAAATTAATGGGGGCAGAAGTTCATCCAGTGGAGGCAGGTACGGGAACTCTCAAAGATGCAACTTCCGAAGCAATTCGAGATTGGGTGACAAATGTGGAAACAACCCATTACATCTTGGGTTCTGTCGCCGGGCCTCATCCTTACCCAATGATTGTCCGTGACTTCCACGCGATAATTGGTATTGAAACTCGCGCTCAATCCCAGGAGAAATGGGAAGGATTACCAGATATTCTACTGGCTTGCGTGGGTGGAGGTTCCAATGCGATCGGCTTGTTCTATGAATTTCTCAATGAACCTTCAATACGTCTAATTGGAGTCGAAGCGGCGGGTGAAGGTGTAAATACAGAAAAACACGCAGCTACCTTGACAAAAGGAAAAATAGGTGTATTGCATGGTGCAATGAGCTATTTACTGCAAGATGATGACGGTCAAATTATCGAAGCTCATTCAATTAGTGCCGGATTAGATTATCCCGGTGTTGGCCCAGAACATAGTTATTTAAAGGATCTTGGTCGCGCCGAGTATTACAGTGTGACTGATAAACAAGCGTTAGAAGCATTTCAACGACTTTCGCAACTAGAAGGAATTATCCCAGCTTTGGAAACTGCTCATGCGATCGCATATCTCGAAACCCTTTGCCCTGAGTTAGAAGGCAGTCCCCGCATTGTCATCAATTGTTCCGGCAGAGGTGACAAAGATGTGCAAACCGTCGCCAAAGTCCTGATTCCTTAA	MVSIQDIKTATIQPDSLGRFGRFGGKYVPETLMPALSELEAAFQKYRNEPSFQAELQNLLRDYVGRPSPLYFAERLTANYARPDGTGPQIYLKREDLNHTGAHKINNALAQVLLAKRMGKQRVIAETGAGQHGVATATVCARFGLRCVIYMGIHDMERQALNVFRMKLMGAEVHPVEAGTGTLKDATSEAIRDWVTNVETTHYILGSVAGPHPYPMIVRDFHAIIGIETRAQSQEKWEGLPDILLACVGGGSNAIGLFYEFLNEPSIRLIGVEAAGEGVNTEKHAATLTKGKIGVLHGAMSYLLQDDDGQIIEAHSISAGLDYPGVGPEHSYLKDLGRAEYYSVTDKQALEAFQRLSQLEGIIPALETAHAIAYLETLCPELEGSPRIVINCSGRGDKDVQTVAKVLIP	MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTFKIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIGIKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISVKEQAILLFRLSQNSLPFSQEAMNSVKEMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREKILEKYLDELVKKS	161.66	gnl|BL_ORD_ID|3857|hsp_num:0	4927			255	492	cloxacillin; oxacillin; cefalotin
BGC0000824.1|Scytonemin_6 # 5067 # 6293 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.436	BGC0000824.1|Scytonemin_6 	5067	6293	-	Loose	700	26.5646	PDC-13	32.14	3006506	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGAAACTCCTGCTAAAATCTGTCAAAATATTAATCTATAGCTTACTTATAGTTAGCGCCTGTGCTGTTACAGTCTTCGCCCACGATCGCATTGGCTACGGACAAGACAAACACTATAGGTATGAAAATCTTCGGGGACAATACGCTCAATTAGCTGTAAGAAAGAACGTAACTGACCTGACACCAGCAGAGAAAGCAGCCTTCGTCAAAGCTATCAAAACCTTAAAAACTACAATTCCCGCAGGTAGCAAGGTCAGTATTTACGACCAATTCGTTGCCATACATCTAGGGGCAACACGCTTGATTCATAATCATAAAGGACATTCCGATGGTTCAGTTCAAGAACTTGCTCATGAAAATGCGGCATTTTTCCCTTGGCATCGAGAATATATCCGCAGATTTGAACAAGCTTTGCAAGCAGTAAACCGAACTGTAACTCTGCCATACTGGGATTGGACAGACCCCAAAGCATTTGATGTAATTTTTAACGATGACTTTCTTGGTTCTAACGGTCAAGGAGTAACCATCAAAATTCCAAATCAGGGGGATTTTACCGGTGGGGCTGTACAAACTGGGGCTTTTGCTGCTGCAAATGGCTGGATTATGAATCCAGAATTAAACCTTGACCCAGATACCGGAACATCATTAGGGACATCACTTGTACGCTTTCTAAAAATACCTCCTGCCACTGATTATCCAGTGCCCAAAAAAGATATTGAGCGTGCCCTGAGTCTTAATAACTATTCTTTATTTCGCCCTGCATTAGAAGGATTTATCTCTGTAGATGAGCAAGGTAAAGTCACCCCCGGAGGATTCATCCACAACTACATTCATGGTTTAGTCGGTGGGGCACAAATAGACGCAAGTACGACACCCGTAACATTTAAGGGTTTAGGGACTATGAGCAATATACCAAGTTCCCCTTACGATCCCGTGTTTTGGTTGCATCATGCCAACGTAGACCGCCTCTGGGCTGAATGGCAAGAAAACGGTCATAAAGGTAGCGATTTTTATCCTGCCGATGGTCAGCCTTACGGACACAATCTTAAAGACCTAATGTGGCCTTGGGACGGCGGGATGTCTACCCCGAAAGCAACGGCGTTAGGGAATTTACTATCCCTATTACCAAAATTTAACCCTAGCGATTTGGTGCGCCCTATAGACGTTTTGAATCACAAGGAACTGGGTTATACCTACGAAACCTGGGAAAGAAAAACGCAAAGATGA	MKLLLKSVKILIYSLLIVSACAVTVFAHDRIGYGQDKHYRYENLRGQYAQLAVRKNVTDLTPAEKAAFVKAIKTLKTTIPAGSKVSIYDQFVAIHLGATRLIHNHKGHSDGSVQELAHENAAFFPWHREYIRRFEQALQAVNRTVTLPYWDWTDPKAFDVIFNDDFLGSNGQGVTIKIPNQGDFTGGAVQTGAFAAANGWIMNPELNLDPDTGTSLGTSLVRFLKIPPATDYPVPKKDIERALSLNNYSLFRPALEGFISVDEQGKVTPGGFIHNYIHGLVGGAQIDASTTPVTFKGLGTMSNIPSSPYDPVFWLHHANVDRLWAEWQENGHKGSDFYPADGQPYGHNLKDLMWPWDGGMSTPKATALGNLLSLLPKFNPSDLVRPIDVLNHKELGYTYETWERKTQR	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRLWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPTAERVKIAYTILSGLEQQGKVPLKR	102.77	gnl|BL_ORD_ID|4196|hsp_num:0	5266			795	957	
BGC0000824.1|Scytonemin_7 # 6411 # 7238 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.458	BGC0000824.1|Scytonemin_7 	6411	7238	-	Loose	450	31.187	BlaB-38	29.33	3005551	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGACCTCTATCTCCAATTCCTTTCAAACTTTACGCGATCGCCAACAGTGTGCTTTAATCCCCTTTATTACAGCAGGCGATCCTAACTTAGAAACCACTGCCCAAGCTTTACGTATCTTAGATCGCAACGGCGCTGACTTCATCGAGTTGGGTATTCCCTACTCTGATCCTCTCGCAGATGGGCCTGTTATTCAAGCAGCCGCAACTCGCGCTTTGCAAAAAGGCACGAAATTAGAACAAGTATTAGAGATGTTGCAAGCTGTAACTCCTACCCTGAAAGCGCCGATAATTCTATTTACTTACTACAATCCCATTTTGCACCGGGGTATTAAGACATTTTTGGCGCAAATTGCTGCTGTTGGGGTGCAAGGGTTGGTAGTGCCAGACTTGCCCTTAGAAGAAGCAGAAGAATTAATCCAAACTGCTGCATCTTTTGGGATTGAGGTAATTTTACTAGTAGCTCCTACCAGTTCTAAAGATAGGATTTTAGCGATCGCTCGTCAATCTCAGGGTTTTATCTACCTGGTAAGCGTCACAGGCGTTACAGGTATCCGCGCTCAAATCCAAGACCGCGTAAAAGATTTAATTACCGACTTGCGAAGCGTCACCGATAAACCCATCGGCGTTGGTTTTGGTATTTCCGGGCCAGAACAAGCGCATCAAGTAAGGGAATGGGGAGCAGATGCCGTGATTGTTGGTAGTGCCTTTGTCAAACGGTTAGCTGAAGGCAGCCCAACCGAAAGACTACAAGCAGTAGAAAAGCTTTGCCAAGAACTGAAAGCAGCAATTACCCCAGTATCCCTGCAACAAGTTGTTTCCGCAAAATAA	MTSISNSFQTLRDRQQCALIPFITAGDPNLETTAQALRILDRNGADFIELGIPYSDPLADGPVIQAAATRALQKGTKLEQVLEMLQAVTPTLKAPIILFTYYNPILHRGIKTFLAQIAAVGVQGLVVPDLPLEEAEELIQTAASFGIEVILLVAPTSSKDRILAIARQSQGFIYLVSVTGVTGIRAQIQDRVKDLITDLRSVTDKPIGVGFGISGPEQAHQVREWGADAVIVGSAFVKRLAEGSPTERLQAVEKLCQELKAAITPVSLQQVVSAK	MLKKIKLTLILAFGFTSLQAFGQENPDVKIEKLKDNLYVYTTYNSYKGVKYAANAVYMVTDKGVVVIDCPWGEEKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLGYFKKIGAKTYSTKMTDSILAKENKPRAEYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGFIGEAYVNDWTQSVHNIQQKFSGAQYIVAGHDDWKDQRSIQHTLDLISEYQQKQKASN	110.44	gnl|BL_ORD_ID|3330|hsp_num:0	4399			96	309	
BGC0000824.1|Scytonemin_8 # 7287 # 7634 # -1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.422	BGC0000824.1|Scytonemin_8 	7287	7634	-	Loose	400	24.6386	vatE	25.45	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	TTGGAGAGAGGTCAAAGTGTATTGCATCCAAGCGAGAAGCGCTATATTACTACTTCAAAAAATGAAGCTCTAATACTCGACGACGGAGCTAAAAGCCTCGTTAACGGAGCTAAAAGACTCGTTAACGGAGATAAAAGACTCGCTGACGGAGATAAAAGACTCGCTGACGGAGATAAAAGACTCGTTAACGGAGATAAAAGACTCGTTAACGGAGCTAAAAGACTCGCTGACGGAGATAAAAGACTCGTTAACGGAGCTAAAAGACTCGCTGACGGAGATAAAAGACTCGTTAACGGAGATAAAAGACTCGACAACAACAAATATAGCGTGGCTATCGCTAATTCCTAA	MERGQSVLHPSEKRYITTSKNEALILDDGAKSLVNGAKRLVNGDKRLADGDKRLADGDKRLVNGDKRLVNGAKRLADGDKRLVNGAKRLADGDKRLVNGDKRLDNNKYSVAIANS	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	53.74	gnl|BL_ORD_ID|1398|hsp_num:0	1519			96	261	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000824.1|Scytonemin_10 # 8724 # 10856 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.420	BGC0000824.1|Scytonemin_10 	8724	10856	-	Loose	450	32.7278	baeR	24.26	3000828	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACACTGCCCTCGAAGATATTCTGTTTCACTTAAATTCTCAGCGTGGCGGTTTGTTAAGAAGCAGCTACGAATATCCAGGGAGATATAAAAGATGGGCGATCGGATTTGTCAATCCACCATTGGAATTGACTACACAGGAAAATGCTTTCAATTTGATAGCGCTGAATGAACGCGGTCTAGTACTTTTACCTTTACTATTAGAGTGTTTATCCAACTCACTCCAACTTGAGAAAGTTACCCTAGACAATAATAATATTGTCGGCTTTGTTAAATCTACCAAGAGATTATTCACTGAAGAAGAACGCAGTAAACAACCTTCGGCATTTACAGTTGTCCGCGAAATTTTACATACTTTCTCTAGCCAAGAAGATGAACATTTAGGATTGTATGGGGCTTTTGGTTATGACTTAGTTTTTCAGTTTGAACCAATAACCCAAAGTCTGGAACGTCCTAAAGATCAGCGCGATTTGGTGCTTTATTTGCCAGATGAATTGATAGTTGTTGACTACTATCAGCAACGCGCATTTCGTCTACAGTATGATTTTGAAACAGCGCACGGCAATACAAAGAATCTGCCTCGAACTGGTGAGTCTGTTGATTATCGAGGCAAACATCTTACCCCTAATGAAACGGCTGACCATAAAGTAGGCGAGTATGCCAAAAAAGTTGAGTCTGCACTCGATTATTTCCGCCGAGGCGATTTATTTGAAGTTGTTCCTAGCCAAAACTTTTTTGAAGGCTATGAAGATGAGCCCAGCAAACTCTTTGAAACTTTAAAGGATATAAATCCTAGTCCTTATGGGTTTATTTTTAATTTAGGTGGAGAATATTTAATTGGCGCATCTCCAGAAATGTTTGTGCGAGTTGAAGGGAAACGGGTAGAAACTTGTCCTATTAGTGGCACTATTAGCCGGGGACTAGATGCTCTTGACGATGCGGTGCAAATTCGTCATTTACTCAACTCCCACAAAGATGAAGCTGAGTTGACCATGTGTACTGATGTCGATCGCAATGACAAATCCCGAATCTGCGAACCTGGTTCAGTACAAGTGATTGGTCGTCGCCAAATTGAATTATACAGCCATTTAATTCATACAGTAGATCATGTTGAAGGGACACTGCGATCGCAATTTGATGCTTTAGATGCCTTTCTTTCCCACACTTGGGCGGTTACAGTCACTGGCGCACCCAAAAAAGCTGCAATAGATTTTATTGAACAGCACGAACGTAGCGCCCGACGTTGGTATGGTGGCGCAGTCGGTTATTTAAATTTCAATGGGAATTTAAATACTGGCTTAATTCTGCGGACAATTCGATTAAAAGACTGCATCGCCGAAGTGCGAGTTGGGGCGACTGTCCTTTATGACTCCATACCCCAAGCAGAAGAACAAGAAACAATCACCAAAGCGGCTGCTTTATTTGAAACGATTCGCCGTGTTAAGCAAAGCAGTCACAAAATTGATGAATCCAGTTCCATAAAATCAACTAAAATCCTACCTTGTGTGGCAACTGGCAAACGCATCTTACTAATAGACTATGAAGACTCTTTTGTTCATACATTAGCTAATTACATTCGCCAAACTGGTGCAAGCGTCACCACATTACGTCATGGTTTCTCAGAAACGCTCTTCGATACAGAACGCCCTGACTTAGTTGTTTTATCTCCTGGCCCTGGTAGACCAAGTGATTTTCGGGTTCCCCAGACTGTCGGGGCGCTTCTTCATCGCAAAATTCCCATTTTTGGAGTTTGTCTAGGTCTGCAAAGCATCGTAGAAGCTTTTGATGGACAATTGGGAGTTCTCAACTATCCTCAACATGGGAAATCTTCACGGATTTTCGTTACTGATTCCGATTCCGTTACCTTCAAGAATTTACCAGAATCCTTTACCGTGGGTAGATATCACTCATTGTTTGCTCTCCCGCAACATTTACCCCAAGAACTGAAGGTGACAGCGATTTCTGATGACAACGTAATTATGGGTATTGAACATCAGACACTTCCCATCGCCGCCGTTCAGTTTCATCCAGAATCAATCATGACTTTAGCGGGAGAAGTCGGTCTGGAAATCATTAAAAATGTCGTGCGTGCATATACACAGGTGGAAGAGTCATTAGTCATTGGTCATTAG	MDTALEDILFHLNSQRGGLLRSSYEYPGRYKRWAIGFVNPPLELTTQENAFNLIALNERGLVLLPLLLECLSNSLQLEKVTLDNNNIVGFVKSTKRLFTEEERSKQPSAFTVVREILHTFSSQEDEHLGLYGAFGYDLVFQFEPITQSLERPKDQRDLVLYLPDELIVVDYYQQRAFRLQYDFETAHGNTKNLPRTGESVDYRGKHLTPNETADHKVGEYAKKVESALDYFRRGDLFEVVPSQNFFEGYEDEPSKLFETLKDINPSPYGFIFNLGGEYLIGASPEMFVRVEGKRVETCPISGTISRGLDALDDAVQIRHLLNSHKDEAELTMCTDVDRNDKSRICEPGSVQVIGRRQIELYSHLIHTVDHVEGTLRSQFDALDAFLSHTWAVTVTGAPKKAAIDFIEQHERSARRWYGGAVGYLNFNGNLNTGLILRTIRLKDCIAEVRVGATVLYDSIPQAEEQETITKAAALFETIRRVKQSSHKIDESSSIKSTKILPCVATGKRILLIDYEDSFVHTLANYIRQTGASVTTLRHGFSETLFDTERPDLVVLSPGPGRPSDFRVPQTVGALLHRKIPIFGVCLGLQSIVEAFDGQLGVLNYPQHGKSSRIFVTDSDSVTFKNLPESFTVGRYHSLFALPQHLPQELKVTAISDDNVIMGIEHQTLPIAAVQFHPESIMTLAGEVGLEIIKNVVRAYTQVEESLVIGH	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV	295.83	gnl|BL_ORD_ID|1231|hsp_num:0	1337			9	393	novobiocin
BGC0000824.1|Scytonemin_11 # 11407 # 12591 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.426	BGC0000824.1|Scytonemin_11 	11407	12591	-	Loose	350	27.335	BcI	32.88	3002877	protein homolog model	n/a	n/a	cephalosporin; penem	antibiotic inactivation	class A Bacillus cereus Bc beta-lactamase	ATGATAGTTGACATCAAGCAAAAAAGTAGATTAATTCATCAACGTGTTTCGGTTAGTTTTAATTATGAGGTTTATTTCACCCAAAATTTATTTGAGTTGAAAAACCCCACCTTAGCGCAAGTAATTTCGGCAGATGAGGAGACAAAGCCGAAGAAAGTAGTTGCAGTAATAGACGCAGGAATATTAAAGTATCAACCGGAATTAGTGAAGCAATTAGTTGCGTATACCAAGTTTTATGGAGAGGTACTAGCGATCGCAGCTGAACCCATGATAATTTCGGGAGGAGAAGCTGCCAAAAACGATCGCACTTTAGTAGAGCAAATCCAGCAACTCATTGAAACAGCCGGATTATGTCGCCATTCTTATGTGTTAGCGATCGGGGGCGGAGCTGTATTGGATTTGGTAGGATATGCTGCTGCAACTGCTCACCGGGGAATTCGCCTGATTCGGGTTCCGACAACGGTGTTAGCACAAAATGATTCTGGGGTTGGAGTGAAAAACGGCATTAATGCCTTTGGTAAAAAGAACTTTCTCGGCACATTTGCGCCACCTTATGCAGTTATAAATGACTCTGCGTTCTTGACAACCCTAGACGATCGCGATTGGCGTTCTGGGATTGCAGAAGCCGTGAAAGTGGCGCTGATTAAGGATGCTAACTTTTTTGATTTTATCCACTCTCACAGCAAAGCCCTTGGGCGGCGAGACATGGATGCTATGCAACAGGTTATCTATCGTTGCGCCCAGTTGCACCTAGAACATATTGCCAATAGCGGCGATCCTTTTGAAATGGGTTCGTCTCGTCCCCTAGATTTTGGACATTGGGCGGCTCATAAACTGGAGCATTTGACAAATTATCGCTTGCGTCATGGCGAAGCTGTTGCGATCGGTATTGCTTTGGATAGCACTTATTCTTATTTAGCAGGATTGCTTGATTGCTCAGAATGGCAACGAATATTAAATACTTTATCAGCGTTGGGTTTCACGCTGTATGTGCCAGAACTGGCCCAGAAATTATCACAACAGGAACATCCTGATTGTTTGTTTCGAGGTTTAACTGAGTTCCGCGAACACTTGGGTGGAGAATTGACTTTAACATTGCTAAAAAATATTGGAAAAGCAATTGAAGTTCATGAAGTAAATTTGTTGTTGTATAGGCAAGCAATATCACTATTGCAGGAATTTTAG	MIVDIKQKSRLIHQRVSVSFNYEVYFTQNLFELKNPTLAQVISADEETKPKKVVAVIDAGILKYQPELVKQLVAYTKFYGEVLAIAAEPMIISGGEAAKNDRTLVEQIQQLIETAGLCRHSYVLAIGGGAVLDLVGYAAATAHRGIRLIRVPTTVLAQNDSGVGVKNGINAFGKKNFLGTFAPPYAVINDSAFLTTLDDRDWRSGIAEAVKVALIKDANFFDFIHSHSKALGRRDMDAMQQVIYRCAQLHLEHIANSGDPFEMGSSRPLDFGHWAAHKLEHLTNYRLRHGEAVAIGIALDSTYSYLAGLLDCSEWQRILNTLSALGFTLYVPELAQKLSQQEHPDCLFRGLTEFREHLGGELTLTLLKNIGKAIEVHEVNLLLYRQAISLLQEF	MKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSNRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGIPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLIAEATKVIVKALR	128.76	gnl|BL_ORD_ID|665|hsp_num:0	720			699	900	
BGC0000824.1|Scytonemin_12 # 12588 # 13232 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.398	BGC0000824.1|Scytonemin_12 	12588	13232	-	Loose	350	26.5646	catB11	29.17	3004660	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCTAATAGATATCTTTCATGATACCGTTTGCCCTTGGTGCAGAATTGGGAAAAAACATCTGTTTGATGCACTGGCAAAATGGCAAGAACAAGAAGTACATATCCGATGGCATCCCTTTCTTCTGGATGATACTGTTCCTGCTGAGGGGTACGAATTTAGAAACTTTATGCAAAATAGAAAGGGCATTAAAGCGGAAGAACTGCAACATCTGTTTGATTATACGCAACGCGAAGGTGAGGCGGCTGGAGTTAAGCTAGATTTTGAAAAAATCCGTTTGGCTGTCAATACTAAGCTTGCTCACCAACTGATTGCATTAGCACCGACAAACATAAAAAATGATGTCGTTGAAGCTATTTATAGAGCTTACTTTGAAGAGGGTTTGAATATTGGAGATATTAACGTTATTGTTGCCATCGGTACAGCATACCAGATGAATGCTACCGAATTAAAGTTGCAATTAAACGATCGCGATGTCGTTGATGCAGTTGTTGCTGAATCGGCATTTGCTCGCTTAAATGGCATCAACAGCGTGCCGTTTTTCATCATGAATAATCAAGTCAAGGTCAATGGTTCTCACTCAGTAGAGGTATTCCTTGAAGCTTTGAATAGTACTGCACTTTTAGATATACCCGCAAAAATATGA	MLIDIFHDTVCPWCRIGKKHLFDALAKWQEQEVHIRWHPFLLDDTVPAEGYEFRNFMQNRKGIKAEELQHLFDYTQREGEAAGVKLDFEKIRLAVNTKLAHQLIALAPTNIKNDVVEAIYRAYFEEGLNIGDINVIVAIGTAYQMNATELKLQLNDRDVVDAVVAESAFARLNGINSVPFFIMNNQVKVNGSHSVEVFLEALNSTALLDIPAKI	MKNYFESPFKGKPLVEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIGSFCSIGTGASFIMAGNQGHRYDWVTSFPFFYMNEEPAFSESVDAFQAAGNTVIGSDVWIGSEAMIMPGVKVGHGAVIGSRALVTKDIEPYTIVGGNPAKEIKKRFSEQEISMLLDMKWWDWPLEQIKEAMPLLCSSDIAGLYHFWQRSSA	101.90	gnl|BL_ORD_ID|2201|hsp_num:0	3360			141	351	chloramphenicol
BGC0000824.1|Scytonemin_13 # 13368 # 14447 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.394	BGC0000824.1|Scytonemin_13 	13368	14447	-	Loose	500	25.409	APH(3')-Vc	29.69	3002651	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGCCTCTGAAATCCTCTTATTCAGATCAGCTTAAAAAAACTGACCAGAGCTTGATCGCCTTACTTAGCGATCGCATATCATTATTAGCATCAGAACAGCCTTCTTTAGATGAACAACTGGCTAGTGTCGCTCCCCTACTCGCTCAAGCTGGTATTCCTGAGTCTGTTTGGGCAGGTGTAGTAAATAGTTGTCATGCCAGCCTTACCCCTAAATCTGCTATAAACCATGCCAGTCCTCGACAAGTTACCATCATCGGTGGACGCGGCAGGATGGGAAGATTATTTCAAGAGCAGCTTTCGCTAGTAGGTCATAATGTTAGCATTCTTGAACATGAAGATTGGGAATATGCAGAGCAACTGTTAAGTCAAGCAGAATTAGTATTAGTAAGTGTTCCTATTGAACATACGGTTGATGTTATCAAGCGGGCAGCAAAATATCTTGCCTCAAATACAGCTTTGTGTGACATCACAAGTATTAAAACACAGCCAACTCAAGCAATGCTCGAACACCATTGTGGTCCCGTCATGGGTTTACATCCAATGTTTGGGCCAAATATTAAATCGTTTTTGGGACAAAAGGTGGTCGTGTGTCCAGGTCGAAATGATGATTCATTTCAATGGTTATTAGACTTTCTTAAAAGTAAAGGTGGTGAATTAATTGTTTGCACGCCTGAAGAACACGATCGGATGATGGTGATTATTCAAGCAACGCAGCATTTTTGTAGATTTAGTCTGGGCGTTTTCTTAGCACAAGCAAGGGTGGAGATAGAGCAGAGTTTAACAATGTCAACTCCTAATTATCGTCAAGAAATTGATATTGTGAAACGTTTGTTTGCTCAAAATCCTAATTTATGTGTTGATATTATGCTAGCTACTGAAGAAAGATGTAATGCTATTAGTTTTTTAGCTAATACTTACAGCCGTTTGGCTAGACTGGTGGCTAGGAAGGATAGAGAGGCATTAATTAAAGAGTTTGAAAATACTCAAAGTTTTTTTGAAGGGAAAATTAACAGTTTTCTCCAGCCTTTAAATACAACGGCTCTCAAAAGAGATTTTAAGCCACAGAATATTGGCATTTGA	MPLKSSYSDQLKKTDQSLIALLSDRISLLASEQPSLDEQLASVAPLLAQAGIPESVWAGVVNSCHASLTPKSAINHASPRQVTIIGGRGRMGRLFQEQLSLVGHNVSILEHEDWEYAEQLLSQAELVLVSVPIEHTVDVIKRAAKYLASNTALCDITSIKTQPTQAMLEHHCGPVMGLHPMFGPNIKSFLGQKVVVCPGRNDDSFQWLLDFLKSKGGELIVCTPEEHDRMMVIIQATQHFCRFSLGVFLAQARVEIEQSLTMSTPNYRQEIDIVKRLFAQNPNLCVDIMLATEERCNAISFLANTYSRLARLVARKDREALIKEFENTQSFFEGKINSFLQPLNTTALKRDFKPQNIGI	MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLTWLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF	135.98	gnl|BL_ORD_ID|634|hsp_num:0	687			540	729	neomycin; ribostamycin; paromomycin
BGC0000824.1|Scytonemin_14 # 14462 # 15751 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.423	BGC0000824.1|Scytonemin_14 	14462	15751	-	Loose	750	28.1054	adeF	34.29	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAAATTCTGATTTATTCATACAACTATCATCCAGAACCAATTGGTATTGCACCTTTGATGACTGAACTAGCAGAAGGCCTAGTGAAGCGAGGGCATCAAGTGCGGGTAATTACAGGTATGCCTAACTATCCTCAGCGCCAGATTTACGATCGCTATCGGGGTAAATTATACGTTACTGAACAGAAAAATGGTGTCAAAATTCAGCGTAGTTACCTGCGGATTAAATCTAAACCCAACCTTATAGACCGACTACTGCTAGAGTTGAGCTTTGTCTTTACAAGTTTGCCACAAGCCCTCAAGGGCGAGCGACCTGATGTAATTCTCTTAACAATACCACCGCTACTAGTTTGTTTACCTGCAACTTTGATAGGTTGGCTATACAACTGCCCAGTAGTGCTGAATGTGCAAGATATCCTCCCGGAAGCTGGTGTACGTGTTGGTCTAATTAAGAATAAGTTGATGATTCAAGCTTTGGAAGCTTTAGAGAAATTTGCTTACCGAACTGCACATACCATTAGCGTCATTGCCGATGGCTTTGTAGATAATCTCATAAATAAAGGTGTACCTGCTAATAAAATTGCCTGCATTCCCAATTGGGTAAATCTAAATTTTATCCGCCCTTTACCAAAGGTAAATAACTCTTGGAGAGCTACCCATCAACTCGATGGTAAATTTGTAGTGCTTTATTCAGGTAATATTGCTCTCACGCAAGGTTTGGAAACAGTAATAGAAGCAGCAGCCCGTTTACGTCATCTAAAAGAAATTATCTTTGTCGTAGCAGGCGAATCTCAAGCACTCGAAAGGTTGCAAAAACATTGTCTTGCTTGTGGTGCAGATAATGTTTTGCTTTTAACGTTGCAAGCGCGAGAAAAACTACCACAAATGTTAGCAGCCGCAGATGTGGGGTTGATTGTACAAAAGTGCAATGTGATTTCCTTCAATATGCCTTCTAAAATACCACTGTTGTTAGCTAGTGGTCGCCCAATTGTGGGTTCAGTTCCCGCCCTTGGGACTGCTGCCAAAGCCATCCGAGAAAGTGGTGGTGGTGTTATCGTTGAACCAGAGTCAGCAGGTGCTTTGGCTGCGGCGGTGCTGGATTTATATCATCAGCCGGAATTAGCAGCGCAATTAGGATGTAAAGGAAGAAAGTTTGCGGTAGAAAACTATTCCTTTGAGCAAGCGCTAGACCGATATGAAGAGCTATTTGCTGATGCGATCGCCAAAAGAGCAACAAACTTGGATATTTTGCCAGAAATGAGTTCTAAGCAATCACTTGTTGATATTTGA	MQILIYSYNYHPEPIGIAPLMTELAEGLVKRGHQVRVITGMPNYPQRQIYDRYRGKLYVTEQKNGVKIQRSYLRIKSKPNLIDRLLLELSFVFTSLPQALKGERPDVILLTIPPLLVCLPATLIGWLYNCPVVLNVQDILPEAGVRVGLIKNKLMIQALEALEKFAYRTAHTISVIADGFVDNLINKGVPANKIACIPNWVNLNFIRPLPKVNNSWRATHQLDGKFVVLYSGNIALTQGLETVIEAAARLRHLKEIIFVVAGESQALERLQKHCLACGADNVLLLTLQAREKLPQMLAAADVGLIVQKCNVISFNMPSKIPLLLASGRPIVGSVPALGTAAKAIRESGGGVIVEPESAGALAAAVLDLYHQPELAAQLGCKGRKFAVENYSFEQALDRYEELFADAIAKRATNLDILPEMSSKQSLVDI	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	40.51	gnl|BL_ORD_ID|132|hsp_num:0	153			1545	1650	tetracycline
BGC0000824.1|Scytonemin_15 # 16005 # 17201 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.468	BGC0000824.1|Scytonemin_15 	16005	17201	-	Loose	550	28.8758	vgbB	43.33	3001308	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGGGATTAGTCAAAAATTTGTCAATCGGCATTCTCGGTACCGGATTCATAGTGTTGACAACAGCAGCCCAAGCCAAGGCTGTAACATTAAGTTACGACAGAAGTATTGGTAGCCCCGGCTTTGGTCCTGGAGAACTCTTTGTTCCCCAAGGCATAACGGTGGATAGCCAAGGGAATACGCTCATAGCTAACGGACGCGGTGTTAACCCGGATGGTACTCCTAACTACAACGTCGGTAACAAAATTGAAAAATTTAGTCCAAGCGGCCAGTATATTGGGGCAATTGGCTCCGGTGGCACAGGGCCCGGACAGTTTGACGAGCCAACAACTGTAGACTTTAATCCCGTAACAGGGGATTTGTATGCAGGTGATGTTTACAACAACCGCATCAATCAATTCGATTCTCAGGGTAACTTTATTAGATCCTTTGCAAATGGAGAATTTACCCCTCTCGTAGAGGGTAGGCTTTTCTTTGGGCCATCTGGTGTGACATTTGACAAAACTGGCAACGTGTACATCGGTGATTTTAATGGCGAAAGAATCCTTAAATTCACACCAGACGGACAGCAAATTGGTGTCATTGGTGGCACTCTGGGCACTGCACCTGGGCAATTCCAAGGTGTAGCAGGTTTAAGAATTTCCCCAGTTAGTGGAAATATCTTTGTAGCTGACCAGTATAACAACCGCGTTCAAGTACTCGATCCAAATGGTAATCCTCTGTTGGCATTTGGTTCAGCAGGTAGCGGACCTGGACAGCTTCTTCAGCCAATTGGCATCGAAGTGGACGACCAAGAGAATGTTTATGTAGCTGATTCTATCAACAGCCGCGTACAGGTGTTTGATAAAAATGGTAACTTCTTGACTTCCTTCGGTGAAAATGCCCGCGATGCATCAGGTAATCCGGTACCGCCTCCAGCATTAACTGGTCCTCCTTTTGGCAATCCCCTCGACCTCACCCCCGGCAGATTTAACTGGACGGGTGGCACAAGCTATAAAGATGGCAAGCTTTACGTGGGCGATTTCTTCCAAGGTCGCGTCCAAGTAATAAACGTAGAGGGCAGAAAGCAAGTACCTGAACCTGGTTCAGCATTAGGTTTAGCATTGCTTGGACTTGGGGCTGCTACCATCACATTGCGGAAACGTGGACAACAAAAGCCAGTCTTCAGTTTAGAGAAAGAACTGCAAAAGCAATGCTGA	MGLVKNLSIGILGTGFIVLTTAAQAKAVTLSYDRSIGSPGFGPGELFVPQGITVDSQGNTLIANGRGVNPDGTPNYNVGNKIEKFSPSGQYIGAIGSGGTGPGQFDEPTTVDFNPVTGDLYAGDVYNNRINQFDSQGNFIRSFANGEFTPLVEGRLFFGPSGVTFDKTGNVYIGDFNGERILKFTPDGQQIGVIGGTLGTAPGQFQGVAGLRISPVSGNIFVADQYNNRVQVLDPNGNPLLAFGSAGSGPGQLLQPIGIEVDDQENVYVADSINSRVQVFDKNGNFLTSFGENARDASGNPVPPPALTGPPFGNPLDLTPGRFNWTGGTSYKDGKLYVGDFFQGRVQVINVEGRKQVPEPGSALGLALLGLGAATITLRKRGQQKPVFSLEKELQKQC	MNFYLEEFNLSIPDSGPYGITSSEDGKVWFTQHKANKISSLDQSGRIKEFEVPTPDAKVMCLIVSSLGDIWFTENGANKIGKLSKKGGFTEYPLPQPDSGPYGITEGLNGDIWFTQLNGDRIGKLTADGTIYEYDLPNKGSYPAFITLGSDNALWFTENQNNSIGRITNTGKLEEYPLPTNAAAPVGITSGNDGALWFVEIMGNKIGRITTTGEISEYDIPTPNARPHAITAGKNSEIWFTEWGANQIGRITNDKTIQEYQLQTENAEPHGITFGKDGSVWFALKCKIGKLNLNE	134.92	gnl|BL_ORD_ID|4679|hsp_num:0	1144			297	387	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000824.1|Scytonemin_17 # 18754 # 19965 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	BGC0000824.1|Scytonemin_17 	18754	19965	-	Loose	550	28.1054	vgbC	25.71	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGAAAGCTGCGTCAGCTGCCTCATTTTCGGTAATCGCCGACGGTTTATATAATGCCGGCGGTCTGAGCTTTAGTCCTGATGGTAATCTCTATGTTACAGAGGCGGGAATAGGGGGAAGTGGCGCTTGCGTTCCACCAGCAAGTGGTCAGGGCGATTCTCTATGCTATGGCACAAGTGGAGCAGTTACCAAAGTTGAGAATGGTAAGACCGAACGCATACTTACAGGACTTCCTTCCTTAGCATTACCAGATGGCACTGGAGCCGCAGGCCCTCGTGATATTAAATTTGATGCTACAGGGAAACCTTATGTTCTGATTGGGTATGCGACTAATCCAGCCTTTCGCGATCGCAATTTAGGTAACACTGACCTCGGCAAAATCATCGCTCCCAACTTTAAAACCAATTCGTGGACGAGTGTTGCCGATTTAGCTAACTATGAACTCGCCAACAATCCCGATGGTGGTGAAGTCGGTAGCAATCCCTTGGGTTTTGTCATAGATGGCAATAAGTTAGTTGCAGTTGATGCAGGGGCAAACGACTTACTCAGCTTTAATGCTGACGGGAGAAATCTGCAAGCTATTACCACATTCCCTGAAGACATATTAGCTAATCCCGTCTTCCCACCCTCCGATACTCCATCCAACGAACCGGCGCAAGTGCCATCTCAAAGTGAAGAAGTGCGATCGGCGCAATTTGCAACCCAAGCAGTACCCTCAAGTGTTACCAAAGGCCCCGATGGTGCTTATTACGTCAGCCAATTTACTGGTTTTCCCTTCCCTGAAGGTGGGGCAAAAATCTATCGAGTTGGTGCTGATGGTTTACCAACAATCTTCGCCGATGGTTTTACCCAACTCACAGACTTGGAATTTGATACTGAGGGCAATTTATATGCTTTGCAGTACGCCAATCAGTCAGCTTGGAAGGGTGATTTTGATGGTTCTGTCATCAAAATAGCTGCTGATGGTACTCGCACAACTCTGCTGAGTGGCAATGGATTAGAGTCGCCTAGCGCCTTGACTATTGGTGCTGATGGTGCGGTATACGTCACAAACCGAGGCGATCGCCCTGGATTTGGACAAGTTCTCAAAATTGAGAATACCAAATCTATCCCTGAACCTGATTCTACTTTAGGCGTATTAGCGATCGCAGCCTTGGGCGTTGGTTGGTTGCACAAGAAGAGAATCCCCACACCTCCCATAAATCTCAACTAA	MKAASAASFSVIADGLYNAGGLSFSPDGNLYVTEAGIGGSGACVPPASGQGDSLCYGTSGAVTKVENGKTERILTGLPSLALPDGTGAAGPRDIKFDATGKPYVLIGYATNPAFRDRNLGNTDLGKIIAPNFKTNSWTSVADLANYELANNPDGGEVGSNPLGFVIDGNKLVAVDAGANDLLSFNADGRNLQAITTFPEDILANPVFPPSDTPSNEPAQVPSQSEEVRSAQFATQAVPSSVTKGPDGAYYVSQFTGFPFPEGGAKIYRVGADGLPTIFADGFTQLTDLEFDTEGNLYALQYANQSAWKGDFDGSVIKIAADGTRTTLLSGNGLESPSALTIGADGAVYVTNRGDRPGFGQVLKIENTKSIPEPDSTLGVLAIAALGVGWLHKKRIPTPPINLN	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	136.15	gnl|BL_ORD_ID|2244|hsp_num:0	2526			420	777	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000824.1|Scytonemin_20 # 22262 # 22549 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.392	BGC0000824.1|Scytonemin_20 	22262	22549	-	Loose	200	23.483	vanX gene in vanF cluster	36.0	3002952	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGGAGCCAAGCAAGTTTCATTTCCAATGGTTTGATTTTAAAAGCTGGGAATCGAATCAGATTCTTATAGACACTACTCTCTTCCGACTCGAAGATTTTTTGAACGAACCGCAAAAGAAGAGACTAAAACACACGAGCATCCCAATCTTCCAAAATTTCACGATGCTGATGCAAAAACCCTTTACAACTCTCTTACCTTCGCGCTCTCTGCGCCCTTTGTGGTTCGTTCTCTTATTCCAGCCAATAACTACATTTACCAAACTGGAACTTCAAATATTTACTTTTTGA	MEPSKFHFQWFDFKSWESNQILIDTTLFRLEDFLNEPQKKRLKHTSIPIFQNFTMLMQKPFTTLLPSRSLRPLWFVLLFQPITTFTKLELQIFTF	MEKDFVFLDEILHGVRWDSKYATWDNFTGKPVDGYEVNRIAGTYALAVALLEVKKQAAALGYGLLLWDGYRPQRAVNCFLHWSAQPEDGRTKERYYPNIDRIEMVTKGYVASKSSHSRGSAIDLTLYRLDTGALVPMGSGFDFMDERSHHTSKGISSNEAQNRQLLCSIMEYSGFESYVYEWWHYVLRNEPYPSSYFDFPIGGNHLDPFSNFCGTVPLDALSP	42.60	gnl|BL_ORD_ID|1499|hsp_num:0	1509			336	474	vancomycin
BGC0000824.1|Scytonemin_21 # 22515 # 24389 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.484	BGC0000824.1|Scytonemin_21 	22515	24389	-	Loose	800	26.5646	mel	27.78	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGAGTCAAAACTATACTGGTTCCAACTCTCCTCTCATCACTACTGAGCCATACAAAGAATTTCCAGCAAATAGATATGTAGAATCTTCTCGTCAGCTTGATGAATCGGAGAATAACGGGGGAACTCAGCCTTTTTTAAATGATGAAACACCAGCAACGCTCTCAGTTGCCGATGCGATCGCTCAGATGTTGGTAAATTTGGGAGTAAGCTACGCTTTTGGTGTAGCGGGTGGTGCAATGGCCAGCCTTTGGGGGGCGCTATCAAATAGCAGCATAGAAGTGTTGAACTTCCGCCATGAAGCTGGAGCAGCCTTTGCAGCCACCGAAGCACACTTTGCCAATAATCGCCCCACTGTAGTTTTTACCACAGCCGGGCCGGGGATCACTAACGCGCTGACCGGATTATTTGCGGCTCGTGGTGAAGGCGCAAAGGTAATTTTGTTGTCGGCTTGCACCTCTGCACCGCAACGTGGACGTTGGGCAATTCAAGAAACCAGCACTTATACATTGCCCAGTGGGGGAATCTTTACCGCAGGAGCGCTATTCAACTATGCAATCACTATTGAATCTGCGGCTCAACTACCGCAGATTTTCCGTAAACTTGCGATGGCTTTGGCGCAACCAGGCGGATTTGTCGCTCATTTGAGCATTCCCACCGGTGTGCAGACAAGTTTAGTTGAGGATGTAGCTTTACCCCAACTAGATGTTACTCCGTTTCCGATGACTGCTTCCAAAGAAGCGATCGCTAAATCGGTAGAGTTATTATCATCTGGCCCCTTTGCTATCTGGGTTGGTTTCGGTGCGCGTGACGCAGCAGAGGAAATCCTTGAACTCGCTGAAAAAACGGGAGCAGCCGTTATGTGTTCCCCCCGTGGTAAAGGTATCTTCCCTGAAGATCATCCCCAGTTTGTTGGTGTCACAGGTTTAGGCGGTCATGCTTCCGTCTTAACTTATATGGAACAGCAACCTCCACTACGCACACTCGTATTAGGAACCCGCCTTGGTGAACCGACTTCTTTCTGGAGTTCGGCGTTAGTTCCAAAAGAAGGTTTCATCCATGTAGATATTGACCCAGAAGTCCCAGGTGTAGCCTATCCACAGGTTGAAACTTTCGGGGTTCGGTCTGATATCAAAGCTTTTGTGGAAGAGTTATTGGAGCAATTACCGGATGCTCCCCGTTCCACAACTTTGTCGCTACCTAATCCAGAACGCAAAGCAATCGAACCTGCACCAGAGGTAGATTATCCAGTGCGGCCAGAAGTATTGATGGCAGCAATTCAAAAGATAATTGTTGAAGGTAGCGATGCAATAGTCATGGCGGAGTGTGGTAACTCATTTACTTGGTCAACGCATCTACTCCAATTTACCGAAACCAATCGTTATCGAGTCAGCACCGGAGTCGGCGCAATGGGTCACGCCGTTACAGGAGTATTGGGTGCAGCATTGGCAAGCAATACCAAGGCGGTAGGCATTGTAGGCGATGGGGCAATGCTGATGAATAACGAAATCAGCACAGCCGTGAAATACAAAATTCCGGCGATTTGGATTGTCCTCAACGATGCACGTTACAACATGTGCCATCAAGGGATGAAAATCTTGGGATTAAAGGGCGCAGATGCCACACTTCCACCGACAAACTTCGCCATGATTGCTCGTGGCATGGGAGCAGAAGCGCTCGTGGTTGTTAGAGAGTCGGATATTGAAGCGGCATTAGAACAAGCGATCGCATCATCTGTTCCCTTTCTCATTGATGTCGTAATTGACGCTGATCGCCCAGCACCTTCTGGTGGACGTAATAAGAGTTTGGCTGCACAAGGAATTAAATCAAGTCCAGCTAAAAATGGAGCCAAGCAAGTTTCATTTCCAATGGTTTGA	MSQNYTGSNSPLITTEPYKEFPANRYVESSRQLDESENNGGTQPFLNDETPATLSVADAIAQMLVNLGVSYAFGVAGGAMASLWGALSNSSIEVLNFRHEAGAAFAATEAHFANNRPTVVFTTAGPGITNALTGLFAARGEGAKVILLSACTSAPQRGRWAIQETSTYTLPSGGIFTAGALFNYAITIESAAQLPQIFRKLAMALAQPGGFVAHLSIPTGVQTSLVEDVALPQLDVTPFPMTASKEAIAKSVELLSSGPFAIWVGFGARDAAEEILELAEKTGAAVMCSPRGKGIFPEDHPQFVGVTGLGGHASVLTYMEQQPPLRTLVLGTRLGEPTSFWSSALVPKEGFIHVDIDPEVPGVAYPQVETFGVRSDIKAFVEELLEQLPDAPRSTTLSLPNPERKAIEPAPEVDYPVRPEVLMAAIQKIIVEGSDAIVMAECGNSFTWSTHLLQFTETNRYRVSTGVGAMGHAVTGVLGAALASNTKAVGIVGDGAMLMNNEISTAVKYKIPAIWIVLNDARYNMCHQGMKILGLKGADATLPPTNFAMIARGMGAEALVVVRESDIEAALEQAIASSVPFLIDVVIDADRPAPSGGRNKSLAAQGIKSSPAKNGAKQVSFPMV	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK	154.07	gnl|BL_ORD_ID|1130|hsp_num:0	1231			855	1110	erythromycin; telithromycin
BGC0000824.1|Scytonemin_22 # 26226 # 28205 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.387	BGC0000824.1|Scytonemin_22 	26226	28205	+	Loose	900	90.8929	basS	25.37	3003583	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	ATGAATTCTGGCGATTATAAACTAGCTAGATCAAACACTCAATGGTCACTACAGCCAGAAATAGAAATGAAGTTTGCTCACTTTCTAATAAATCAAGCTGTAGATGCTGCCTTTTGTTTAGGAGAAAATGCACAGTTTCTCTACGTCAACGATGCCACTTGCCGGATGACTGAGTATTCCCGTGAGGAATTACTTTCCATGAGGCTGCAAGATATAGATGTAGATTTTTCTCTACACAACTGGTCAAACATTAACTCAGAAGGTTCTCTTACCTTTAAATCTCGTTACCGCACAAAACGAGGGCGGATCTTTCTGGTAGAAATATCCATTAGCTATGTAAAGCAACAAGATATAGAATTTGGCTGTGCTTTCGTTCGGGAAATAAGTGATGAAATAGTAGAACTGAGCGTGCAAAAATGGACTGATGGATTAAGAGATGCCAAAGACAATTTGCAGCAGGAGTTTTCTCAACTCAAATCAAAAGAAATAGAACTAGAAGCATCTCTTTCTTTACTTCGTTCTACTCTCGAATCTACTGCCATTGGTATTGTTGCAGTTAACTCTGAGGGAGATATTCTGAGCTTGAATCAGAAATTTGTGGATATGTGGCAGATCCCAGAGTCCCTAATATTATCAAAGAAATGTCCTCGATGCAAAGCCTTTTTTGAGAATAAACTTAAAGATCCACAAGCCTTTAATCGACTAATTTGGGAAGTGTCTAGCCAATCTGATTTCGAGAGCTACGATATTTTGGAATTGAAAGATGGGAGAGTTTTTGCACACTACTCTAAGCCTCACTTGTTGGATGGCAAAATTATTGGTAGAGTCTGGAGTATTTGGGACATTACTGAATCGAAACAGACTGAAGAGGCATTGCGGCTAAACGCAGTTAGATTTCGGACTTTAGCTGAAACAACAGATACCAGCACTTTTCTAATTCAAGGTACGCGGCTTTGCTACATAAATCCAGCAGTAGAGCAACTGACTGGTTATACAAAAGAGGAACTGTTAACGGGTTTTGATCTTCGCCGACTGATTAAAAGCAAAAGACGTAGGCAGGTACGTAAGCAGAGTGAAGCAACTAACTTTGAATACCAAGAGATGAATATTCTGACAAAAAGCGGTACGGAGCGCTGGCTAGCTTGTGCGGTTGTAATGCTGGATGGTGTGCTAGATTTTGGTGGGAAACCAGTAGAAATGATTGCAGGCATTGATATTACCGATTACAAATATGCAGAATTAGGTCTTAACCAAGCTTTAGAACAAGCAAAACAACTTAGCGAACTTAGAGCACGTTTTCTTTCTATGGTTTGCCATCAATTCCGTACACCGTTGAATATTGTTTCATTTTCTAATAGTTTATTAAAGGAAGAAGTAGACAAACGTACACAGAAGAAAATCCAACCACTGCTGGATCACATTCAAAAAGCCACCGAACAACTCGGTCAGATGTTGGATGATATTTTATTCTTCTCTAAGGCAGAAGCAGAAAAAATAAACTATGAGCCAAAGCCACTTGAGTTAGTTGATTTCTGTAATGACTTAGTTGCAGAAATGCAGATGACCATTAGCAAAATTCGGATTAATTTTGTCACTCAAGAAAATTCTCTAACAGCCTGCATAGACAAAAAACTGTTAGAGCCGATTTTAAAAAATTTGCTCGATAATGCAATAAAATATTCTCCCTCTGGTATAACAGTTGATTTGAGACTTTCTTGCGAAAATGAGCAATTAATTTTCCAGGTCGAAGATAGAGGTATTGGTATTTCAGCGCTAGATCAACAACGAATATTTGAACCATTTTACCGTGGAACTAATATCGATCGCATACCTGGCACTGGACTAGGACTGTCAATTCTTAAAACCTTGGTAGACTTACATCATGGTCAAGTATCTGTGGAAAGTCAACTTGGTGTGGGCACTACCTTTACTGTGACGTTGGCATTAATCAAGTCAGAGTTTAGTAGTTCCGAGTTATGA	MNSGDYKLARSNTQWSLQPEIEMKFAHFLINQAVDAAFCLGENAQFLYVNDATCRMTEYSREELLSMRLQDIDVDFSLHNWSNINSEGSLTFKSRYRTKRGRIFLVEISISYVKQQDIEFGCAFVREISDEIVELSVQKWTDGLRDAKDNLQQEFSQLKSKEIELEASLSLLRSTLESTAIGIVAVNSEGDILSLNQKFVDMWQIPESLILSKKCPRCKAFFENKLKDPQAFNRLIWEVSSQSDFESYDILELKDGRVFAHYSKPHLLDGKIIGRVWSIWDITESKQTEEALRLNAVRFRTLAETTDTSTFLIQGTRLCYINPAVEQLTGYTKEELLTGFDLRRLIKSKRRRQVRKQSEATNFEYQEMNILTKSGTERWLACAVVMLDGVLDFGGKPVEMIAGIDITDYKYAELGLNQALEQAKQLSELRARFLSMVCHQFRTPLNIVSFSNSLLKEEVDKRTQKKIQPLLDHIQKATEQLGQMLDDILFFSKAEAEKINYEPKPLELVDFCNDLVAEMQMTISKIRINFVTQENSLTACIDKKLLEPILKNLLDNAIKYSPSGITVDLRLSCENEQLIFQVEDRGIGISALDQQRIFEPFYRGTNIDRIPGTGLGLSILKTLVDLHHGQVSVESQLGVGTTFTVTLALIKSEFSSSEL	MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI	138.16	gnl|BL_ORD_ID|2350|hsp_num:0	249			711	1314	polymyxin B
BGC0000824.1|Scytonemin_23 # 28403 # 29254 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.411	BGC0000824.1|Scytonemin_23 	28403	29254	+	Loose	400	71.2478	vanR gene in vanM cluster	35.16	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGTACGAATCGTCAAATAAAATTCTCGTCATTGAAGATGATAATATTACCCGCGATCTTTATTTAAAAGGTCTTAAGGCTAAAGGTTTTGATACAATCAGTGCTGACAACGGTTTTGCTGGTATCCAACAAGCACTAGAGTGTATACCCGACTTAGTGATTTGCGATATCACGATGCCCGATATGGATGGTTATAGCGTTTTAAATACGCTACGCCAAGATCCTCTTACGGCAATTATTCCCTTTATTTTTCTGACTGGGAGTAGTAACAAAGCAGATGTTCGCAAAGCTATGGAATTGGGAGCAGATGATTATCTTACCAAACCCTCGACACTAGATGAATTGCTCAGAGCGATCGCTATCCGACTAGAAAAGCAAGCTACTCTGCAATACTGGTGGGCTAAGAAATTTGAGAAAGCTCCAAAATCAGTATTTGTAGATCATACTCCAAGTGCGATCGCATCTGAAGAAACTTCTGATGAAGAAGCCACAATCCCTTCTAAGTCAATCTTTCCCTGTATTCCTCAATTAAAAGAAGTTTTCGACTTTATCGAAGCCCATTATCATCAAGGAATTACTTTGTGTGATGTGGCTGTTGCTGTTGGTTACTCACCTGCTTACTTAACTAACCGAGTCGCAAGGCAAACGGGAGAGACTGTAAACTGCTGGATTGTCAAACGCCGAATGGCAGGCGCTCGTTTTTTACTCCAAAATAATAATCAGACTATCGAGAAGATCGCCAAAGCATTAGGTTATCAAGATGTGTCTCATTTTTCTCGCCAATTTCGCCAACATCACGGTTTACCTCCCCAAGCTTGGCGCAAACAGCATCAGCTTGTATCTCAAAAATAG	MYESSNKILVIEDDNITRDLYLKGLKAKGFDTISADNGFAGIQQALECIPDLVICDITMPDMDGYSVLNTLRQDPLTAIIPFIFLTGSSNKADVRKAMELGADDYLTKPSTLDELLRAIAIRLEKQATLQYWWAKKFEKAPKSVFVDHTPSAIASEETSDEEATIPSKSIFPCIPQLKEVFDFIEAHYHQGITLCDVAVAVGYSPAYLTNRVARQTGETVNCWIVKRRMAGARFLLQNNNQTIEKIAKALGYQDVSHFSRQFRQHHGLPPQAWRKQHQLVSQK	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	121.98	gnl|BL_ORD_ID|4735|hsp_num:0	752			15	378	vancomycin; teicoplanin
